Description
Section I. Introduction 1. Parkinson’s disease and related disorders: The pursuit for reliable readouts and the role of neuroimaging 2. Advances in magnetic resonance imaging 3. Advances in molecular neuromaging methodology Section II. Clinical Applications in Parkinson’s Disease 4. Dopaminergic molecular imaging in familial and idiopathic Parkinson’s disease 5. Serotonergic molecular imaging in familial and idiopathic PD 6. Molecular imaging beyond dopamine and serotonin in familial and idiopathic Parkinson’s disease 7. Structural MRI in familial and idiopathic PD 8. Functional MRI in familial and idiopathic PD 9. Molecular imaging in prodromal Parkinson’s disease Section III. Clinical Applications in Lewy Body Dementias 10. Molecular imaging evidence in favor or against PDD and DLB overlap 11. Magnetic resonance imaging in Parkinson’s disease with mild cognitive impairment, Parkinson’s disease dementia, and dementia with Lewy bodies Section IV. Clinical Applications in Atypical Parkinsonian Disorders 12. Neuroimaging in multiple system atrophy 13. Neuroimaging in progressive supranuclear palsy 14. Neuroimaging in corticobasal syndrome Section V. Clinical Applications in Other Movement Disorders 15. Molecular imaging in Huntington’s disease 16. Magnetic resonance imaging in Huntington’s disease 17. Neuroimaging in essential tremor 18. Neuroimaging in restless legs syndrome 19. Neuroimaging in dystonia 20. Demyelinating syndromes and movement disorders
